## Correct Answer: HBV Structure **Key Point:** HBV is an *enveloped* DNA virus, not non-enveloped. This is a critical structural distinction that affects transmission, stability, and vaccine design. ### HBV Genome & Envelope - HBV is a **partially double-stranded circular DNA virus** (not single-stranded) - It possesses a **lipid bilayer envelope** derived from the host hepatocyte membrane - The envelope contains HBsAg (surface antigen), which is the basis for HBV vaccines - Because it is enveloped, HBV is **sensitive to detergents, heat, and drying** — unlike non-enveloped viruses ### Correct Serological Sequence in Acute HBV | Marker | Appearance | Significance | |--------|------------|---------------| | **HBsAg** | First (appears ~4–10 weeks) | Indicates active infection | | **Anti-HBc IgM** | Early (within 1–2 weeks of HBsAg) | **Earliest specific marker** of acute infection | | **HBeAg** | Follows HBsAg | Indicates high replication; correlates with infectivity | | **Anti-HBe** | Late | Indicates declining viral replication | | **Anti-HBs** | Last (appears after HBsAg clearance) | Indicates recovery and immunity | **High-Yield:** Anti-HBc IgM is the **gold standard** for diagnosing acute HBV in a patient with HBsAg positivity. It distinguishes acute from chronic infection. **Clinical Pearl:** A patient who is HBsAg-positive but Anti-HBc IgM-negative is likely in chronic infection, not acute. ### Why the Other Options Are Correct - **Option 0 (HBsAg before HBeAg):** True. HBsAg appears first (~4–10 weeks), HBeAg follows (~4–12 weeks). - **Option 1 (Anti-HBc IgM earliest):** True. Anti-HBc IgM appears within 1–2 weeks of symptom onset, making it the earliest specific serological marker. - **Option 3 (HBeAg and infectivity):** True. HBeAg positivity strongly correlates with HBV DNA levels and transmissibility.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.